Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. April 2026 10:44 ET | Quelle: Research and Markets

Vabysmo (F. Hoffmann-La Roche) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts 2020-2035

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Vabysmo Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
14. April 2026 10:44 ET | Quelle: Genmab A/S

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; April 14, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital...
14. April 2026 10:43 ET | Quelle: Research and Markets

Uplizna Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts 2020-2035

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Uplizna Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's...
14. April 2026 10:00 ET | Quelle: Zealand Pharma

Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations

Zealand Pharma appoints Eric Rojas, Vice President, Head of Investor Relations, effective April 15, 2026.
14. April 2026 10:00 ET | Quelle: HiberCell, Inc.

HiberCell to Present Preclinical Data Demonstrating the Enhanced Antitumor Activity of HC-7366 in Combination with VEGFR-TKIs in Clear Cell Renal Cell Carcinoma (ccRCC)

ROSEVILLE, Minn., April 14, 2026 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today...
14. April 2026 10:00 ET | Quelle: Neion Bio, Inc.

Neion Bio Strengthens Genome Engineering Leadership with Appointment of Colossal Biosciences Veteran James Kehler

Neion Bio names Colossal Biosciences veteran James Kehler as Head of Avian Sciences, strengthening its genome engineering leadership.
14. April 2026 09:00 ET | Quelle: Merakris Therapeutics

Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model

Merakris’ MTX-001 research wins SAWC award; human data show significant wound healing. Phase 2 ongoing with FDA and manufacturing catalysts ahead.
14. April 2026 09:00 ET | Quelle: Neomorph, Inc.

Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting

Presentation in the New Drugs on the Horizon session to feature the development of NEO-811, a novel ARNT (HIF-1β)-targeted therapy in clear cell renal cell carcinoma (ccRCC) Three additional...
14. April 2026 09:00 ET | Quelle: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors

LOS ANGELES, April 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises REGENXBIO, Inc., (“REGENXBIO” or the "Company") (NASDAQ: RGNX) investors of a class action on behalf of investors that...
14. April 2026 08:45 ET | Quelle: Actuate Therapeutics

Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Median overall survival increased by >40% in elraglusib arm compared to the control arm, with a 1-year survival rate of 44% in the elraglusib arm versus 22% in the control arm 18-month survival...

Vorherige Seite

Nächste Seite